Back to User profile » Dr Luigi Bottaro
Papers published by Dr Luigi Bottaro:
Semaglutide 2.4 mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective
Torre E, Di Matteo S, Martinotti C, Bruno GM, Cabrino A, Fogliati EL, Giusti A, Barbieri M, Bottaro LC, Colombo GL
ClinicoEconomics and Outcomes Research 2026, 18:585328
Published Date: 1 May 2026
Economic Evaluation of Once-Weekly Insulin Icodec from Italian NHS Perspective
Torre E, Di Matteo S, Bruno GM, Martinotti C, Bottaro LC, Colombo GL
ClinicoEconomics and Outcomes Research 2024, 16:799-811
Published Date: 6 November 2024
Economic Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Italy. Analysis and Perspectives
Torre E, Di Matteo S, Martinotti C, Bruno GM, Goglia U, Testino G, Rebora A, Bottaro LC, Colombo GL
ClinicoEconomics and Outcomes Research 2024, 16:773-784
Published Date: 24 October 2024
Economic Burden of Non-Alcoholic Steatohepatitis (NASH) Among Diabetic Population in Italy: Analysis and Perspectives
Torre E, Di Matteo S, Bruno GM, Martinotti C, Valentino MC, Testino G, Rebora A, Bottaro LC, Colombo GL
ClinicoEconomics and Outcomes Research 2022, 14:607-618
Published Date: 14 September 2022
Economic Evaluation of Dulaglutide vs Traditional Therapies: Implications of the Outcomes of the Rewind Study
Torre E, Bruno GM, Di Matteo S, Martinotti C, Valentino MC, Bottaro LC, Colombo GL
ClinicoEconomics and Outcomes Research 2020, 12:177-189
Published Date: 8 April 2020